Drugs and double binds: racial identification and pharmacogenomics in a system of binary race logic

Health Communication
John Lynch, Tasha N Dubriwny

Abstract

People respond to drugs in different ways depending on their genotype. Some geneticists and medical researchers have suggested using race as a substitute for genotype in prescribing medication. Overall, individuals resist the prescription of medication based on race, but some minority individuals, although indicating resistance and suspicion, ultimately choose race-based medication. This can be explained by the operation of Burkean identification in a system of binary race logic. Although individuals resist race-based medication and recognize race is not a legitimate genetic category, their identification with a racial-ethnic group places them in a double bind between choosing race-based medication or denying their racial identification.

References

Aug 22, 2000·Progress in Cardiovascular Nursing·L S Evangelista, K Dracup
Nov 15, 2000·American Journal of Public Health·A H Goodman
Feb 24, 2001·Science·U HoffrageG Gigerenzer
May 3, 2001·The New England Journal of Medicine·C W YancyUNKNOWN U.S. Carvedilol Heart Failure Study Group
May 3, 2001·The New England Journal of Medicine·R S Schwartz
May 9, 2001·Science·B Butterworth
Aug 10, 2001·American Journal of Epidemiology·J S Kaufman, R S Cooper
Oct 31, 2001·Nature Genetics·J F WilsonD B Goldstein
Mar 13, 2002·Critical Care Medicine·Lesley StevensJoseph McMullin
Mar 29, 2002·Perspectives in Biology and Medicine·Lundy Braun
Jun 5, 2002·Genome Research·Morris W Foster, Richard R Sharp
Jun 18, 2002·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Ellen Wright Clayton
Nov 20, 2002·Archives of Internal Medicine·Giselle Corbie-SmithDiane Marie M St George
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Feb 7, 2003·The New England Journal of Medicine·Richard Weinshilboum
Feb 7, 2003·The New England Journal of Medicine·William E Evans, Howard L McLeod
Mar 21, 2003·The New England Journal of Medicine·Richard S CooperRyk Ward
Mar 21, 2003·The New England Journal of Medicine·Esteban González BurchardNeil Risch
Jul 2, 2003·Diabetes Care·Andrew John Karter
Aug 9, 2003·The New England Journal of Medicine·Ellen Wright Clayton
Sep 23, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Celeste ConditTina M Harris
Sep 23, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Jennifer L BevanCeleste M Condit
Feb 5, 2005·Community Genetics·Tasha N DubriwnyJennifer L Bevan

❮ Previous
Next ❯

Citations

Sep 13, 2006·Health Communication·William Evans
Sep 13, 2011·Journal of Microbiological Methods·Hueman Jaimes-DíazKenneth Loren Beattie
Dec 9, 2008·The Journal of Nursing Research : JNR·Mei-Ju ChenAllen Wen-Hsiang Chiu
Oct 29, 2008·Journal of Women's Health·Yun-An ChouNicole Huang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.